Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells

British Journal of Pharmacology

Volumn 119, Issue 6, 1996, Pages 1117-1124

  Pinzani, Massimo ^a   Marra, Fabio ^a   Caligiuri, Alessandra ^a   DeFranco, Raffaella ^a   Gentilini, Alessandra ^a   Failli, Paola ^a   Gentilini, Paolo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cyclic AMP; Extracellular signal regulated kinase (ERK); Hepatic fibrosis; Hepatic stellate cells (HSCs); Intracellular calcium; Mitogen activated protein kinase (MAPK); Pentoxifylline; Phosphatidylinositol 3 kinase (PI 3 K); Platelet derived growth factor (PDGF)

Indexed keywords

ANTITHROMBOCYTIC AGENT; CALCIUM ION; COLLAGEN; CYCLIC AMP; MESSENGER RNA; PENTOXIFYLLINE; PHOSPHATIDYLINOSITOL KINASE; PHOSPHOTRANSFERASE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN C FOS;

ARTICLE; AUTOPHOSPHORYLATION; CELL PROLIFERATION; COLLAGEN DEGRADATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LIVER FIBROSIS; MESSENGER RNA SYNTHESIS; MITOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STELLATE CELL;

EID: 0029958518     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16012.x     Document Type: Article

References (41)

1. BERMAN, B., MATTHEW, R. & DUNCAN, R. (1989). Pentoxifylline inhibits normal human dermal fibroblasts in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity. J. Invest. Dermatol., 92, 605-610.
2. BOIGK, G., RAETSCH, C., STROETER, L., WALDSCHMIDT, J., HERBST, H., RIECKEN, E.O. & SCHUPPAN, D. (1995). Antifibrotic effect of pentoxifylline in rat biliary fibrosis due to bile duct obstruction. J. Hepatol., 23, 142 (Abstract).
3. ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J., 11, 4211-4220.
4. CASINI, A., PINZANI, M., MILANI, S., GRAPPONE, C., GALLI, G., JEZEQUEL, A.M., SCHUPPAN, D., ROTELLA, C.M. & SURRENTI, C., (1993). Regulation of extracellular matrix synthesis by transforming growth factor β1 in human fat-storing cells. Gastroenterology, 105, 245-253.
5. CHANG, C.C., CHANG, T.C., KAO, S.C.S., KUO, Y.F. & CHIEN, L.F. (1993). Pentoxifylline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial myxoedema. Acta Endocrinol., 129, 322-327.
6. CHAO, T-S.O., BYRON, K.L., LEE, K-M., VILLEREAL, M. & ROSNER, M.R. (1992). Activation of MAP kinases by calcium-dependent and calcium-independent pathways. Stimulation by thapsigargin and epidermal growth factor. J. Biol. Chem., 267, 19876-19883.
7. CHOMCZYNSKI, P. & SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
8. CLAESSON-WELSH, L. (1994). Platelet-derived receptor signals. J. Biol. Chem., 269, 32023-32026.
9. COHEN, G.B., REN, R. & BALTIMORE, D. (1995). Molecular binding domain in signal transduction proteins. Cell, 80, 237-248.
10. COOK, S.J. & MCCORMICK, F. (1993). Inhibition by cAMP of Ras-dependent activation of Raf. Science, 262, 1069-1072.
11. COOPER, D.M., MONS, N. & KARPEN, J.W. (1995). Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature, 374, 421-424.
12. DUNCAN, M.R., HASAN, A. & BERMAN, B. (1995). Pentoxifylline, pentifylline, and interferons decrease type I and type III procollagen mRNA levels in dermal fibroblasts: evidence for mediation by nuclear factor 1 down-regulation. J. Invest. Dermatol., 104, 282-286.
13. FAILLI, P., RUOCCO, C., DE FRANCO, R., CALIGIURI, A., GENTILINI, A., GIOTTI, A., GENTILINI, P. & PINZANI, M. (1995). The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx. Am. J. Physiol. Cell Physiol., 269, C1133-C1139.
14. FRIEDMAN, S.L. (1993). The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies. N. Engl. J. Med., 328, 1828-1835.
15. 2+ pump by cyclic nucleotides in cultured vascular smooth muscle cells. J. Biol. Chem., 263, 8058-8065.
16. GHOSH CHOUDHURY, G., WANG, L.-M., PIERCE, J., HARVEY, S.A., & SAKAGUCHi, A.Y. (1991). A mutational analysis of phosphatidylinositol-3-kinase activation by human colony-stimulating factor-1 receptor. J. Biol. Chem., 266, 8068-8072.
17. GRAVES, L.M., BORNFELDT, K.E., RAINES, E.W., POTTS, B.C., MACDONALD, S.G., ROSS, R. & KREBS, E.G. (1993). Protein kinase A antagonizes platelet-derived growth factor-induced signalling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc. Natl. Acad. Sci. U.S.A., 90, 10300-10304.
18. LALLI, E. & SASSONE-CORSI, P. (1994). Signal transduction and gene regulation: the nuclear response to cAMP. J. Biol. Chem., 269, 17359-17362.
19. MAK, K.M. & LIEBER, C.S. (1988). Lipocytes and transitional cells in alcoholic liver disease: a morphometric study. Hepatology, 8, 1027-1033.
20. MARRA, F., PINZANI, M., DEFRANCO, R., LAFFI, G. & GENTILINI, P. (1995a). Involvement of phosphatidylinositol 3-kinase in the activation of extracellular signal-regulated kinase by PDGF in hepatic stellate cells. FEBS Lett., 376, 141-145.
21. MARRA, F., PINZANI, M., LAFFI, G. & GENTILINI P. (1995b). Phosphatidylinositol 3-kinase mediates PDGF mitogenic signalling in hepatic stellate cells. J. Hepatol., 23(Suppl. 1), 132 (Abstract).
22. MARRA, F., VALENTE, A.J., PINZANI, M. & ABBOUD, H.E. (1993). Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J. Clin. Invest., 92, 1674-1680.
23. MARSHALL, C.J. (1995). Specificity of receptor tyrosine signalling: transient versus sustained extracellular signal-regulated kinase activation. Cell, 80, 179-185.
24. mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. U.S.A., 90, 8319-8323.
25. PARKER, P.J. & WATERFIELD, M.D. (1992). Phosphatidylinositol 3-kinase: a novel effector. Cell Growth Differ., 3, 747-752.
26. PAWSON, T. (1995). Protein modules and signalling networks. Nature, 373, 573-580.
27. PETERSON, T. (1993). Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts. Hepatology, 17, 486-493.
28. PINZANI, M. (1995). Novel insight into the biology and physiology of the Ito cell. Pharmac. Ther., 66, 387-412.
29. PINZANI, M., ABBOUD, H.E., GESUALDO, L & ABBOUD, S.L. (1992a). Regulation of macrophage-colony stimulating factor in liver fat-storing cells by peptide growth factors. Am. J. Physiol. Cell Physiol., 262, C876-C881.
30. PINZANI, M., FAILLI, P., RUOCCO, C., CASINI, A., MILANI, S., BALDI, E., GIOTTI, A. & GENTILINI, P. (1992b). Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J. Clin. Invest., 90, 642-646.
31. PINZANI, M., GENTILINI, A., CALIGIURI, A., DEFRANCO, R., PELLEGRINI, G., MILANI, S., MARRA, F. & GENTILINI, P. (1995). Transforming growth factor-β1 regulates platelet-derived growth factor β subunit in human liver fat-storing cells. Hepatology, 21, 232-239.
32. PINZANI, M., GESUALDO, L., SABBAH, G.M. & ABBOUD, H.E. (1989). Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J. Clin. Invest., 84, 1786-1793.
33. PINZANI, M., KNAUSS, T.C., PIERCE, G.F., HSIEH, P., KENNEY, W., DUBYAK, G.R. & ABBOUD, H.E. (1991). Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells. Am. J. Physiol. Cell Physiol., 260, C485-C491.
34. PINZANI, M., MILANI, S., GRAPPONE, C., WEBER, F.L., Jr, GENTILINI, P. & ABBOUD, H.E. (1994). Expression of platelet-derived growth-factor in a model of acute liver injury. Hepatology, 19, 701-707.
35. PINZANI, M., MILANI, S., HERBST, H., DEFRANCO, R., GRAPPONE, C., GENTILINI, A., CALIGIURI, A., PELLEGRINI, G., NGO, D.V., ROMANELLI, R.G. & GENTILINI, P. (1996). Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am. J. Pathol., 148, 785-800.
36. ROESLER, W.J., GRAHAM, J.G., KOLEN, R., KLEMM, D.J. & MCFIE, P.J. (1995). The cAMP response element binding protein synergizes with other transcription factors to mediate cAMP responsiveness. J. Biol. Chem., 270, 8225-8232.
37. STEFANOVICH, V., VON POLMITZ, M. & REISER, M. (1974). Inhibition of various cyclic AMP phosphodiesterase by pentoxifylline and theophylline. Drugs, 24, 1747-1751.
38. VALIUS, M. & KAZLAUKAS, A. (1993). Phospholipase C-gamma and phosphatidylinositol 3-kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell, 73, 321-324.
39. WANG, Y.Z., POUYSSEGUR, J. & DUNN, M.J. (1994). Endothelin stimulates mitogen-activated protein-kinase activity in mesangial cells through ET(A). J. Am. Soc. Nephrol., 5, 1074-1080.
40. WARD, A. & CLISSOLD, S.P. (1987). Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic effects. Drugs, 34, 50-97.
41. WU, J., DENT, P., JELINEK, T., WOLFMAN, A., WEBER, M.J. & STURGILL, T.W. (1993). Inhibition of the EGF-activated MAP kinase signalling pathway by adenosine 3′,5′-monophosphate. Science, 262, 1065-1069.